Pharmaceuticals

Mon, 07/26/2010 - 17:44

Sanofi Pasteur's Shenzhen vaccine facility starts test runs

Shanghai. July 26. INTERFAX-CHINA - Sanofi Pasteur, the vaccine division of French pharmaceutical giant Sanofi-Aventis Group, has completed first phase construction of its influenza vaccine production facility in Shenzhen City, Guangdong Province, a local newspaper reported July 24.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW